177 related articles for article (PubMed ID: 35261891)
1. Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer.
Hofmann S; Cohen-Harazi R; Maizels Y; Koman I
Transl Cancer Res; 2022 Jan; 11(1):134-147. PubMed ID: 35261891
[TBL] [Abstract][Full Text] [Related]
2. Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.
Halfter K; Hoffmann O; Ditsch N; Ahne M; Arnold F; Paepke S; Grab D; Bauerfeind I; Mayer B
J Transl Med; 2016 May; 14(1):112. PubMed ID: 27142386
[TBL] [Abstract][Full Text] [Related]
3. 3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance.
Hong S; Song JM
Acta Biomater; 2022 Jan; 138():228-239. PubMed ID: 34718182
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.
Prince E; Kheiri S; Wang Y; Xu F; Cruickshank J; Topolskaia V; Tao H; Young EWK; McGuigan AP; Cescon DW; Kumacheva E
Adv Healthc Mater; 2022 Jan; 11(1):e2101085. PubMed ID: 34636180
[TBL] [Abstract][Full Text] [Related]
5. Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine.
Jeppesen M; Hagel G; Glenthoj A; Vainer B; Ibsen P; Harling H; Thastrup O; Jørgensen LN; Thastrup J
PLoS One; 2017; 12(9):e0183074. PubMed ID: 28877221
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer.
Linxweiler J; Hammer M; Muhs S; Kohn M; Pryalukhin A; Veith C; Bohle RM; Stöckle M; Junker K; Saar M
J Cancer Res Clin Oncol; 2019 Mar; 145(3):551-559. PubMed ID: 30474758
[TBL] [Abstract][Full Text] [Related]
7. Uniform Tumor Spheroids on Surface-Optimized Microfluidic Biochips for Reproducible Drug Screening and Personalized Medicine.
Azizipour N; Avazpour R; Weber MH; Sawan M; Ajji A; Rosenzweig DH
Micromachines (Basel); 2022 Apr; 13(4):. PubMed ID: 35457892
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
9. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
[No Abstract] [Full Text] [Related]
10. Heterotypic Tumor Spheroids in Agitation-Based Cultures: A Scaffold-Free Cell Model That Sustains Long-Term Survival of Endothelial Cells.
Franchi-Mendes T; Lopes N; Brito C
Front Bioeng Biotechnol; 2021; 9():649949. PubMed ID: 34178955
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.
Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244
[TBL] [Abstract][Full Text] [Related]
12. Establishing an In Vitro 3D Spheroid Model to Study Medulloblastoma Drug Response and Tumor Dissemination.
Roper SJ; Coyle B
Curr Protoc; 2022 Jan; 2(1):e357. PubMed ID: 35080813
[TBL] [Abstract][Full Text] [Related]
13. Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
Hagemann J; Jacobi C; Hahn M; Schmid V; Welz C; Schwenk-Zieger S; Stauber R; Baumeister P; Becker S
Anticancer Res; 2017 May; 37(5):2201-2210. PubMed ID: 28476783
[TBL] [Abstract][Full Text] [Related]
14. Human-derived Tumor-On-Chip model to study the heterogeneity of breast cancer tissue.
Jeibouei S; Monfared AK; Hojat A; Aref AR; Shams F; Dolati M; Moradi A; Hosseini M; Javadi SM; Ajoudanian M; Molavi Z; Moghaddam M; Mohammadi F; Nuoroozi G; Naeimi SK; Shahani M; Zali H; Akbari ME; Mostafavi E
Biomater Adv; 2024 Jun; 162():213915. PubMed ID: 38878646
[TBL] [Abstract][Full Text] [Related]
15. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
[TBL] [Abstract][Full Text] [Related]
16. A novel design of microfluidic platform for metronomic combinatorial chemotherapy drug screening based on 3D tumor spheroid model.
Sankar S; Mehta V; Ravi S; Sharma CS; Rath SN
Biomed Microdevices; 2021 Oct; 23(4):50. PubMed ID: 34596764
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture.
Baker AEG; Bahlmann LC; Tam RY; Liu JC; Ganesh AN; Mitrousis N; Marcellus R; Spears M; Bartlett JMS; Cescon DW; Bader GD; Shoichet MS
Adv Mater; 2019 Sep; 31(36):e1901166. PubMed ID: 31322299
[TBL] [Abstract][Full Text] [Related]
18. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
19. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
20. Rapid Microfluidic Formation of Uniform Patient-Derived Breast Tumor Spheroids.
Wu Z; Gong Z; Ao Z; Xu J; Cai H; Muhsen M; Heaps S; Bondesson M; Guo S; Guo F
ACS Appl Bio Mater; 2020 Sep; 3(9):6273-6283. PubMed ID: 35021758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
